May 19 - THERADIAG SA ALTHE.PA :
* REPORTED ON MONDAY THERADIAG: VIREMIA TEST BY MIKROGEN,
AMPLICUBE CORONAVIRUS SARS-COV-2 (RT-PCR), WAS APPROVED BY
NATIONAL REFERENCE CENTER OF PARIS
* EXCLUSIVE DISTRIBUTION OF TEST, IN FRANCE, WILL SOON BEGIN
VIA
THERADIAG'S COMMERCIAL NETWORKS
* FOR TIME BEING, NO SIGNIFICANT IMPACT IS BEING ESTIMATED
ON
COMPANY'S 2020 SALES IN ITS FORECASTS
Source text for Eikon: urn:newsml:reuters.com:*:nBw7NJV8sa
Further company coverage: ALTHE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com ; +48 58 7785110))